Jo SH - Search Results

1

Prognostic Impact of Intravascular Imaging-Guided Percutaneous Coronary Intervention in Chronic Total Occlusion.

Hong D, Kim SM, Lee SY, Choi KH, Song YB, Lee JY, Lee SJ, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Lee JM; RENOVATE-COMPLEX-PCI Investigators. Hong D, et al. Among authors: jo sh. Circulation. 2023 Sep 12;148(11):903-905. doi: 10.1161/CIRCULATIONAHA.123.065876. Epub 2023 Sep 11. Circulation. 2023. PMID: 37695832 No abstract available.

2

Long-term safety and efficacy of sirolimus- vs. paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trial.

Kim HS, Lee JH, Lee SW, Kim YH, Park JH, Choi SW, Jeong JO, Seong IW, Rhee KS, Ko JK, Jo SH, Choi YJ. Kim HS, et al. Among authors: jo sh. Int J Cardiol. 2011 Mar 3;147(2):253-7. doi: 10.1016/j.ijcard.2009.09.466. Epub 2009 Sep 26. Int J Cardiol. 2011. PMID: 19783056 Clinical Trial.

3

Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.

Park KW, Chae IH, Lim DS, Han KR, Yang HM, Lee HY, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Jo SH, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Gwon HC, Jang YS, Kim HS. Park KW, et al. Among authors: jo sh. J Am Coll Cardiol. 2011 Oct 25;58(18):1844-54. doi: 10.1016/j.jacc.2011.07.031. J Am Coll Cardiol. 2011. PMID: 22018294 Free article. Clinical Trial.

4

Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Hahn JY, Kim HJ, Choi YJ, Jo SH, Kim HJ, Lee S, Ahn KJ, Song YB, Choi JH, Choi SH, Choi YJ, Lee KH, Lee SH, Gwon HC. Hahn JY, et al. Among authors: jo sh. Am Heart J. 2011 Dec;162(6):1026-33. doi: 10.1016/j.ahj.2011.08.011. Am Heart J. 2011. PMID: 22137076 Clinical Trial.

5

High-dose atorvastatin for preventing contrast-induced nephropathy in primary percutaneous coronary intervention.

Jo SH, Hahn JY, Lee SY, Kim HJ, Song YB, Choi JH, Choi SH, Lee SH, Gwon HC. Jo SH, et al. J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):213-9. doi: 10.2459/JCM.0000000000000157. J Cardiovasc Med (Hagerstown). 2015. PMID: 25032713 Clinical Trial.

6

The impact of renin-angiotensin-aldosterone system blockade on contrast-induced nephropathy: a meta-analysis of 12 studies with 4,493 patients.

Jo SH, Lee JM, Park J, Kim HS. Jo SH, et al. Cardiology. 2015;130(1):4-14. doi: 10.1159/000366473. Epub 2014 Nov 21. Cardiology. 2015. PMID: 25428235

7

The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test.

Shin DI, Baek SH, Her SH, Han SH, Ahn Y, Park KH, Kim DS, Yang TH, Choi DJ, Suh JW, Kwon HM, Lee BK, Gwon HC, Rha SW, Jo SH. Shin DI, et al. Among authors: jo sh. JACC Cardiovasc Interv. 2015 Jun;8(7):914-23. doi: 10.1016/j.jcin.2014.12.249. Epub 2015 May 20. JACC Cardiovasc Interv. 2015. PMID: 26003026 Free article.

8

Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis.

Kim DW, Her SH, Ahn Y, Shin DI, Han SH, Kim DS, Choi DJ, Kwon HM, Gwon HC, Jo SH, Rha SW, Baek SH. Kim DW, et al. Among authors: jo sh. Int J Cardiol. 2018 Feb 1;252:6-12. doi: 10.1016/j.ijcard.2017.08.052. Int J Cardiol. 2018. PMID: 29249438

9

Impact of multi-vessel vasospastic angina on cardiovascular outcome.

Han SH, Lee KY, Her SH, Ahn Y, Park KH, Kim DS, Yang TH, Choi DJ, Suh JW, Kwon HM, Lee BK, Gwon HC, Rha SW, Jo SH, Ko KP, Baek SH. Han SH, et al. Among authors: jo sh. Atherosclerosis. 2019 Feb;281:107-113. doi: 10.1016/j.atherosclerosis.2018.12.018. Epub 2018 Dec 23. Atherosclerosis. 2019. PMID: 30658185

10

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease　- Propensity Score Matching Analysis.

Kim HJ, Lee MH, Jo SH, Seo WW, Kim SE, Kim KJ, Choi JO, Ahn HS, Choi DJ, Ryu KH. Kim HJ, et al. Among authors: jo sh. Circ J. 2019 Dec 25;84(1):83-90. doi: 10.1253/circj.CJ-19-0782. Epub 2019 Nov 28. Circ J. 2019. PMID: 31776309 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

449 results

Search Page